Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report16 July 2021
Urenco has submitted its first CDP disclosure. Formally known as the Carbon Disclosure Project, it is a publicly available database of carbon, water and forest-related performance for companies. Its mission is "we focus investors, companies and cities on taking urgent action to build a truly sustainable economy by measuring and understanding their environmental impact". We have disclosed our 2020 carbon performance, climate risks and mitigation, targets and given examples of our energy policy engagement work.
Dave Sexton, Chief Operating Officer, comments:
“Our first ever CDP disclosure supports our commitment to achieving net zero carbon in advance of 2040 and is an important part of our refreshed sustainability strategy. It allows us to benchmark our carbon performance and management against other companies, including our customers and competitors and aims to bolster our ESG (environmental, social and governance) ratings from external agencies. It also gives us the credibility that underpins our advocacy work on promoting nuclear as being part of the solution for a balanced net zero energy grid. We will submit an update to the CDP each year to publicly and transparently demonstrate our commitment and progress towards net zero carbon.”
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries